Common questions about Lonsurf (FAQ)
Q: Does Lonsurf work by shrinking tumors or by stopping their growth?
The mechanism of action for Lonsurf is described as disrupting the DNA processes of cancer cells to inhibit their ability to grow and proliferate. This leads to cytotoxicity, or cell death. Clinical studies that support the medicine’s use examine patient outcomes related to Objective Response Rate and Disease Control Rate, which reflect how the cancer is affected.
Q: Can Lonsurf be used alone (monotherapy) or is it always used in combination?
According to official product information, Lonsurf can be used either as a single agent (monotherapy) for specific patients with metastatic gastric or gastroesophageal junction adenocarcinoma, or in combination with the medicine bevacizumab for specific patients with metastatic colorectal cancer. Its use is determined by the patient’s specific condition and prior treatments.
Q: Does Lonsurf typically cause hair loss?
Hair loss, or alopecia, has been reported as a side effect in clinical studies of Lonsurf. Official product information lists this as a common adverse reaction, meaning it occurs in up to 1 in 10 patients.
Q: Can Lonsurf be affected by over-the-counter medicines or supplements?
Regulatory documents explicitly focus on interactions with specific antiviral medicines, as well as the approved combination with bevacizumab. Official guidance indicates that patients should inform their healthcare team of all medicines, including over-the-counter products, supplements, or herbal teas they are taking.
Q: What birth control precautions are described for females taking Lonsurf?
Due to the potential for harm to a developing fetus, women of reproductive potential must use adequate contraception during treatment and for six months after the last dose. However, the core regulatory summary does not specify the particular type of contraception that is considered adequate.
Q: What happens if I need a surgery while on Lonsurf?
Patient resources generally highlight that patients should consult with their healthcare team before receiving any surgery or other medical procedures. This is to ensure the procedures can be timed appropriately around the medicine’s treatment cycles and to manage any potential risks.
Q: What common side effects can lead to a delay in the treatment cycle?
The initiation or continuation of a Lonsurf treatment cycle is conditional upon the patient’s body meeting specific laboratory thresholds for blood cell counts. Because the medicine can cause myelosuppression (low blood counts), side effects like low Absolute Neutrophil Count or low platelets can require a dose interruption or delay the start of the next cycle.
Q: Is Lonsurf described as being for patients who have already tried other treatments?
Yes, official indications state that Lonsurf is for adult patients whose disease has progressed despite prior standard treatments, which include previous rounds of chemotherapy and targeted agents. This means it is generally used after other treatment approaches have been tried.
Q: How does Lonsurf work differently from standard fluoropyrimidine-based treatments?
The active component, trifluridine, is a fluorinated thymidine analogue that directly disrupts DNA function. Official documents explicitly state that trifluridine is not a prodrug of 5-fluorouracil (5-FU), which is the component used in standard fluoropyrimidine chemotherapy. This gives it a distinct functional mechanism.
Q: Are there any dietary restrictions or foods to avoid while on Lonsurf?
Official instructions only mandate that the medicine be taken with food within one hour after completion of both the morning and evening meals. Some patient resources suggest avoiding foods that are overly spicy, salty, or acidic, as these may increase the chance of experiencing gastrointestinal side effects.
Q: What is the storage temperature required for Lonsurf tablets?
According to official regulatory sources, Lonsurf must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F). Maintaining the medicine within this temperature range is necessary for proper storage as defined by official labeling.
Q: Can Lonsurf be kept in a pill box or must it stay in its original container?
The tablets must be stored in the original container with the desiccant packet and the cap tightly closed to protect against moisture. Patient education materials recommend that if a pill box is used, it should be a separate, dedicated container and that special handling precautions should be followed when it is being filled.
Q: Does Lonsurf affect fertility?
Based on animal studies, the medicine is known to cause embryo-foetal toxicity, which is why mandatory contraception rules are in place for both men and women. The potential effect on adult human fertility is not fully established in regulatory documents.
Q: Are there different strengths of Lonsurf tablets?
Yes, Lonsurf is available in two different strengths, based on the dose of the trifluridine component: a 15 mg strength and a 20 mg strength. Both strengths contain a fixed ratio of the two active ingredients.
Q: Do patients always use Lonsurf for a full 28-day cycle?
Official documents state that treatment is continued for as long as a clinical benefit is observed or until unacceptable toxicity occurs. Dose interruptions or reductions may be required if specific toxicity thresholds are not met, meaning a full 28-day cycle is not always completed without adjustment.
Q: Can Lonsurf cause changes in liver function blood tests?
Abnormal results in liver function blood tests have been reported as a common side effect, especially when Lonsurf is used in combination with bevacizumab. Due to this risk, the drug is restricted in patients who have pre-existing moderate or severe hepatic impairment.
Q: Why is it important for a caregiver to wear gloves when handling Lonsurf?
Lonsurf is classified as a cytotoxic drug, which means it can be toxic to living cells and requires special handling and disposal procedures. Patient safety instructions often state that a caregiver should wear gloves when handling the tablets to minimize direct exposure.
Q: Is Lonsurf a common or standard first-line treatment for cancer?
The medicine is indicated for patients who have progressed despite prior standard treatments. This means it is typically used later in the course of therapy for patients with metastatic disease, rather than as a standard first-line treatment.
Q: Is it described as normal to feel dizzy after taking Lonsurf?
Dizziness is a symptom that is mentioned in patient safety information as something to monitor. Official information indicates that patients should not drive or operate machinery until they know how the medicine affects them, particularly if they feel dizzy or drowsy.
Q: Does Lonsurf cause a metallic taste in the mouth?
Changes in the sense of taste, known as dysgeusia, are reported as a common side effect in official patient information. This class of side effect includes symptoms like a metallic or altered taste in the mouth.
Q: Can Lonsurf cause a change in skin color or rash?
Skin problems, such as the appearance of a rash, itchy skin, or flaky skin, have been reported as side effects in patient-facing resources. These should be monitored and reported to the healthcare provider if they occur.
Q: Does Lonsurf interact with common pain relievers?
The official interaction profile focuses on specific antivirals and co-administration with bevacizumab. The label does not list common over-the-counter pain relievers as specific interacting medicines, but it is indicated that patients should discuss all products they take with their healthcare provider.
Q: Can Lonsurf affect a patient's ability to drive or operate machinery?
Official patient information states that patients should not drive or operate machinery until they know how the medicine affects them. This precaution is advised particularly if a patient experiences side effects like drowsiness or dizziness.
Q: Is the tablet size the same for all mg strengths?
No, the two available strengths of Lonsurf tablets, 15 mg and 20 mg, are visually distinct. Official documentation states they differ in both size (diameter) and color to help distinguish them.
Q: Can Lonsurf be taken at the same time as all other medications?
The primary administration rule is related to taking the medicine with food within one hour of meals. The regulatory label does not strictly mandate separating the dose from all other medications; only those with known interactions are highlighted for caution.
Q: How long does Lonsurf remain in the body's fluids after the last dose?
Regulatory review documents provide pharmacokinetic information on the two active components. The half-life of trifluridine is approximately 2.1 hours, and the half-life of tipiracil is approximately 2.4 hours.
Q: Are there any known issues with Lonsurf for patients who have lactose intolerance?
According to the Summary of Product Characteristics, Lonsurf tablets contain lactose monohydrate as an inactive ingredient, or excipient. Official information highlights that patients who have lactose intolerance should consult with their healthcare provider regarding this excipient.
